Annette Bruls
Known title: CVP, EMEACLACIK: 0002032351
Associated companies
Transaction History
| EW | ▼ Sell | Open Market | 2,644 | $238K | 8/28/2026 | View on chart |
| EW | ▼ Sell | Tax Withholding | 109 | $10K | 7/11/2026 | View on chart |
| EW | ▼ Sell | Tax Withholding | 84 | $7K | 5/8/2026 | View on chart |
| EW | ▲ Buy | Grant | 6,650 | $0 | 5/7/2026 | View on chart |
| EW | ▼ Sell | Tax Withholding | 109 | $9K | 7/11/2025 | View on chart |
| EW | ▲ Buy | Grant | 6,200 | $0 | 5/8/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
EW: FDA Flags High-Risk Device Recall After Patient Death
The U.S. Food and Drug Administration flagged a potentially high-risk issue with Edwards Lifesciences' SAPIEN M3 delivery system, specifically the Commander M system, after a patient death was reported. The company has instructed customers to remove four specific lots of the device from use. This regulatory action highlights a significant safety concern for the company's key product line, drawing close regulatory scrutiny.
EW: FDA Flags High-Risk Device Recall After Patient Death. The U.S. Food and Drug Administration flagged a potentially high-risk issue with Edwards Lifesciences' SAPIEN M3 delivery system, specifically the Commander M system, after a patient death was reported. The company has instructed customers to remove four specific lots of the device from use. This regulatory action highlights a significant safety concern for the company's key product line, drawing close regulatory scrutiny.